α-Ketoglutaramate-A Key Metabolite Contributing to Glutamine Addiction in Cancer Cells
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Cooper A, Dorai T, Pinto J, Denton T Biology (Basel). 2023; 12(8).
PMID: 37627015 PMC: 10452834. DOI: 10.3390/biology12081131.
Nguyen T, Katt W, Cerione R Future Drug Discov. 2023; 4(4):FDD79.
PMID: 37009252 PMC: 10051075. DOI: 10.4155/fdd-2022-0011.
References
1.
Dorai T, Pinto J, Denton T, Krasnikov B, Cooper A
. The metabolic importance of the glutaminase II pathway in normal and cancerous cells. Anal Biochem. 2020; 644:114083.
DOI: 10.1016/j.ab.2020.114083.
View
2.
Hoerner C, Chen V, Fan A
. The 'Achilles Heel' of Metabolism in Renal Cell Carcinoma: Glutaminase Inhibition as a Rational Treatment Strategy. Kidney Cancer. 2019; 3(1):15-29.
PMC: 6400133.
DOI: 10.3233/KCA-180043.
View
3.
Meister A, TICE S
. Transamination from glutamine to alpha-keto acids. J Biol Chem. 1950; 187(1):173-87.
View
4.
Delgir S, Bastami M, Ilkhani K, Safi A, Seif F, Alivand M
. The pathways related to glutamine metabolism, glutamine inhibitors and their implication for improving the efficiency of chemotherapy in triple-negative breast cancer. Mutat Res Rev Mutat Res. 2021; 787:108366.
DOI: 10.1016/j.mrrev.2021.108366.
View
5.
Hersh L
. Rat liver omega-amidase. Purification and properties. Biochemistry. 1971; 10(15):2884-91.
DOI: 10.1021/bi00791a014.
View